Key result
Aspirin therapy is supported for both secondary and primary prevention of cardiovascular events in selected at-risk adult populations, though current practice patterns may be suboptimal.
Why the study?
Does aspirin prevent cardiovascular events in at-risk adult patients for primary and secondary prevention?
Population
At-risk adult patients and selected population groups for primary and secondary prevention of cardiovascular…
Design
Review
Authors
Loading...
Supports aspirin consideration in selected adults; leaves open strategies to address suboptimal practice patterns.
Does aspirin prevent cardiovascular events in at-risk adult patients for primary and secondary prevention?
Aspirin remains a simple and inexpensive prophylactic measure for primary and secondary prevention of cardiovascular disease in at-risk adults, though its clinical use may be suboptimal.
Ittaman et al. (2014) conducted a review in Cardiovascular disease. Aspirin was evaluated on Cardiovascular events. Aspirin therapy is supported for both secondary and primary prevention of cardiovascular events in selected at-risk adult populations, though current practice patterns may be suboptimal.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: